Eugenia Litz | executive |
Ameet Mallik | executive |
Kristen Harrington-Smith | executive |
Mohamed Zaki | executive |
Jose Carmona | executive |
Gregory Renza | analyst |
Naureen Quibria | analyst |
Brian Cheng | analyst |
Welcome to the ADC Therapeutics Third Quarter 2023 Financial Results Conference Call. My name is Kathy and I will be your operator for today's call.[Operator Instructions] I'll now turn the call over to Eugenia Litz, Vice President of Investor Relations and Corporate Communications. Eugenia, you may now begin.
Thank you, operator. This morning we issued a press release announcing our third quarter 2023 financial results and business updates.